TKTajana Filipec Kanižaj

Tajana Filipec Kanižaj

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tajana Filipec Kanižaj has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Aortic balloon valvuloplasty as a bridge to liver transplantation in a patient with severe aortic stenosis and end-stage liver disease

    by Vlado-Vlaho Ćubela, Maro Dragičević, Joško Bulum, Tajana Filipec Kanižaj, Helena Jerkić

  • Open Access

    Cardiovascular mortality in liver and kidney transplant recipients

    by Zrinka Sertić, Tomislav Letilović, Tajana Filipec Kanižaj, Mladen Knotek, Irzal Hadžibegović, Inga Starovečki, Helena Jerkić

    Previous studies have demonstrated cardiovascular causes to be among the leading causes of death after liver (LT) and kidney transplantation (KT). Although both recipient populations have unique pre-transplant cardiovascular burdens, they share similarities in post-transplant exposure to cardiovascular risk factors. The aim of this study was to compare cardiovascular mortality after LT and KT. We analyzed causes of death in 370 consecutive LT and 207 KT recipients from in-hospital records at a single tertiary transplant center. Cardiovascular causes of death were defined as cardiac arrest, heart failure, pulmonary embolism, or myocardial infarction. After a median follow-up of 36.5 months, infection was the most common cause of death in both cohorts, followed by cardiovascular causes in KT recipients and graft-related causes in LT recipients in whom cardiovascular causes were the third most common. Cumulative incidence curves for cardiovascular mortality computed with death from other causes as the competing risk were not significantly different (P = .36). While 1-year cumulative cardiovascular mortality was similar (1.6% after LT and 1.5% after KT), the estimated 4-year probability was higher post-KT (3.8% vs. 1.6%). Significant pre-transplant risk factors for overall mortality after KT in multivariable analysis were age at transplantation, left ventricular ejection fraction <50%, and diastolic dysfunction grade 2 or greater, while significant risk factors for cardiovascular mortality were peripheral artery disease and left ventricular ejection fraction <50%. In the LT group no variables remained significant in a multivariable model for either overall or cardiovascular mortality. The present study found no significant overall difference in cardiovascular mortality after LT and KT. While LT and KT recipients may have similar early cardiovascular mortality, long-term risk is potentially lower after LT. Differing characteristics of cardiovascular death between these two patient populations should be further investigated.


  • Cardiovascular risk profile and adverse events in renal and liver transplant recipients

    by Helena Jerkić, Zrinka Sertić, Mladen Knotek, Tajana Filipec Kanižaj, Mario Stipinović, Darko Počanić, Damir Kozmar, Tomislav Letilović